Select Question Set:
Q. No.Root knot in Tobacco is caused by the nematode:
1. Heterodera avenae
2. Anguina tritici
3. Globodera pallida
4. Meloidogyne incognita
Subtopic: Interference RNA Tech |
98%
Level 1: 80%+
Please attempt this question first.
Hints
Please attempt this question first.
RNA interference involves silencing of a specific mRNA due to a complementary:
| 1. | dsRNA molecule | 2. | ssRNA molecule |
| 3. | dsDNA molecule | 4. | ssDNA molecule |
Subtopic: Interference RNA Tech |
85%
Level 1: 80%+
Please attempt this question first.
Hints
Please attempt this question first.
Mobile genetic elements:
1. Only I is correct
2. Only II is correct
3. Both I and II are correct
4. Both I and II are incorrect
| I: | are called as transposons. |
| II: | can be a source for complementary dsRNA molecule involved in RNAi in eukaryotic cells. |
1. Only I is correct
2. Only II is correct
3. Both I and II are correct
4. Both I and II are incorrect
Subtopic: Interference RNA Tech |
91%
Level 1: 80%+
Please attempt this question first.
Hints
Please attempt this question first.
What was used to introduce Meloidogyne incognita-specific genes into the tobacco plant for silencing the specific mRNA of the nematode?
| 1. | Gene gun | 2. | Microinjection |
| 3. | Agrobacterium | 4. | Liposome |
Subtopic: Interference RNA Tech |
91%
Level 1: 80%+
Please attempt this question first.
Hints
Please attempt this question first.
The first recombinant therapeutic product approved for human use was:
1. Flavr Savr
2. EPO
3. Human Growth Hormone
4. Human Insulin
1. Flavr Savr
2. EPO
3. Human Growth Hormone
4. Human Insulin
Subtopic: Med Applications & Humulin |
95%
Level 1: 80%+
Please attempt this question first.
Hints
Please attempt this question first.
Which peptide, present in the pro-insulin, is absent from the final structure of insulin?
1. The A peptide
2. The B peptide
3. The C peptide
4. The A and C peptides
1. The A peptide
2. The B peptide
3. The C peptide
4. The A and C peptides
Subtopic: Med Applications & Humulin |
97%
Level 1: 80%+
Please attempt this question first.
Hints
Please attempt this question first.
Eli Lilly prepared two DNA sequences corresponding to A and B chains of human insulin and introduced them in:
| 1. | plasmids of E. coli to produce insulin chains. |
| 2. | pBR322 plasmids to produce insulin chains. |
| 3. | pUC101 plasmids to produce insulin chains. |
| 4. | Ti plasmids of Agrobacterium to produce insulin chains. |
Subtopic: Med Applications & Humulin |
91%
Level 1: 80%+
Please attempt this question first.
Hints
Please attempt this question first.
Insulin isolated from other animals and used in humans:
1. Only I is correct
2. Only II is correct
3. Both I and II are correct
4. Both I and II are incorrect
| I: | will be just as effective as that secreted by the human body itself. |
| II: | would not elicit an immune response in the human body. |
1. Only I is correct
2. Only II is correct
3. Both I and II are correct
4. Both I and II are incorrect
Subtopic: Med Applications & Humulin |
59%
Level 3: 35%-60%
Please attempt this question first.
Hints
Please attempt this question first.
The first clinical gene therapy was given in 1990 to a 4-year old girl with:
1. X-linked severe combined immunodeficiency
2. Adenosine deaminase (ADA) deficiency
3. Purine nucleoside phosphorylase deficiency
4. Omenn syndrome
1. X-linked severe combined immunodeficiency
2. Adenosine deaminase (ADA) deficiency
3. Purine nucleoside phosphorylase deficiency
4. Omenn syndrome
Subtopic: Gene Therapy |
98%
Level 1: 80%+
Please attempt this question first.
Hints
Please attempt this question first.
Consider the given two statements:
| Statement I: | In some children, ADA deficiency can be cured by bone marrow transplantation; in others, it can be treated by enzyme replacement therapy. |
| Statement II: | Both these approaches are completely curative. |
| 1. | Statement I is correct; Statement II is correct |
| 2. | Statement I is correct; Statement II is incorrect |
| 3. | Statement I is incorrect; Statement II is correct |
| 4. | Statement I is incorrect; Statement II is incorrect |
Subtopic: Gene Therapy |
86%
Level 1: 80%+
Please attempt this question first.
Hints
Please attempt this question first.
Select Question Set:
© 2025 GoodEd Technologies Pvt. Ltd.